Want to see HK:8049 full AI Analyst Report?
Total Valuation
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has a market cap or net worth of HK$1.29B. The enterprise value is HK$1.27B.
Market CapHK$1.29B
Enterprise ValueHK$1.27B
Share Statistics
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 172,500,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding172,500,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.34%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.34%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee1.21M
Profits Per Employee354.98K
Employee Count745
Asset Turnover0.34
Inventory Turnover1.91
Valuation Ratios
The current PE Ratio of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H is 5.6. Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s PEG ratio is 0.92.
PE Ratio5.6
PS Ratio1.22
PB Ratio0.65
Price to Fair Value0.65
Price to FCF3.65
Price to Operating Cash Flow0.00
PEG Ratio0.92
Income Statement
In the last 12 months, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H had revenue of 901.87M and earned 198.88M in profits. Earnings per share was 0.35.
Revenue901.87M
Gross Profit757.67M
Operating Income214.60M
Pretax Income264.46M
Net Income198.88M
EBITDA294.19M
Earnings Per Share (EPS)0.35
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pays an annual dividend of HK$0.287, resulting in a dividend yield of ―
Dividend Per ShareHK$0.287
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change18.74%
50-Day Moving Average2.24
200-Day Moving Average2.00
Relative Strength Index (RSI)50.08
Average Volume (3m)47.79K
Important Dates
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H upcoming earnings date is Aug 19, 2026, TBA (Not Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H as a current ratio of 1.30, with Debt / Equity ratio of 0.02%
Current Ratio1.30
Quick Ratio1.22
Debt to Market Cap<0.01
Net Debt to EBITDA-0.49
Interest Coverage Ratio154.72
Taxes
In the past 12 months, Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has paid 65.58M in taxes.
Income Tax65.58M
Effective Tax Rate0.25
Enterprise Valuation
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H EV to EBITDA ratio is 3.24, with an EV/FCF ratio of 3.17.
EV to Sales1.06
EV to EBITDA3.24
EV to Free Cash Flow3.17
EV to Operating Cash Flow3.05
Balance Sheet
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has HK$748.30M in cash and marketable securities with HK$72.40M in debt, giving a net cash position of HK$675.90M billion.
Cash & Marketable SecuritiesHK$748.30M
Total DebtHK$72.40M
Net CashHK$675.90M
Net Cash Per ShareHK$3.92
Tangible Book Value Per ShareHK$2.92
Margins
Gross margin is 84.01%, with operating margin of 23.80%, and net profit margin of 22.05%.
Gross Margin84.01%
Operating Margin23.80%
Pretax Margin29.32%
Net Profit Margin22.05%
EBITDA Margin32.62%
EBIT Margin29.48%
Analyst Forecast
The average price target for Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.39%
EPS Growth Forecast7.94%